Скачать или смотреть Vadim Nazarov on How AI Can Help the Drug Discovery Process | VibeCast Epsiode 23

In this episode, VibeCast host Ray Dogum speaks with Vadim Nazarov, Co Founder and CEO of ImmunoMind, about How AI Can Help the Drug Discovery Process.

Guest Bio:
Vadim Nazarov is a AI and Life Sciences researcher turned startup founder. 2x founder in AI and Biotech: ImmunoMind (AI for Drug Discovery; CEO, current role) and Tensorpad (MLOps; ex-Chief AI Officer / Chief Product Officer).
Built products used by three Top 5 Big Pharma and four Top 10 US universities to develop novel immunotherapies. MSc, PhD cand. in CS. Ex-senior scientist and group leader with 800+ scientific citations in AI and T-cell immunology.
Alumnus of Berkeley SkyDeck, UCSF Innovation Ventures, accepted to Creative Destruction Lab. Alumni council board member at Berkeley SkyDeck. Venture Partner at emerging US-based VC fund for Life Sciences, responsible for European and Techbio / AI / AI for Drug Discovery investments.

Guest Links:
LinkedIn:   / vdnaz  

About VibeCast
VibeCast is our weekly informational podcast and content series exploring the hottest topics in drug development and Web3 with some of the dynamic people that make up the Vibe community. VibeCast is a collection of long-form and short-form video content intended to help our community learn about the current opportunities and challenges in biotech fundraising and community engagement innovation.

Guests will include biotech founders, regulatory experts, drug development executives, blockchain technologists, web3 community builders, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments.

Follow Vibe Bio's Socials:
  / vibebio  
  / vibe-bio  
  / vibebiotechnology  
  / vibebio  
  / vibebiotechnology  

Disclaimer: VibeCast is intended to be used for educational and entertainment purposes, and no information or opinions shared constitute advice or services. While guests are invited to listen, listeners acknowledge they are not being provided professional advice from the podcast or the guests. The podcast is for private non-commercial use and guests do not necessarily reflect any agency, organization, or company that they work for.